PyInvesting

Market research

IL3.F Integra LifeSciences Holdings Corporation

F EUR Healthcare

Latest close

10.8 —

As of 29 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
879M
P/E ratio
80.71
Analyst target
77.7
Dividend yield
Not available
Beta
1.21

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 7 months ago

Integra LifeSciences Holdings Corporation is currently in a long term uptrend where the price is trading 9.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.

Integra LifeSciences Holdings Corporation's total revenue sank by 1.6% to $389M since the same quarter in the previous year.

Its net income has increased by 505.4% to $93M since the same quarter in the previous year.

Finally, its free cash flow grew by 7.2% to $72M since the same quarter in the previous year.

Based on the above factors, Integra LifeSciences Holdings Corporation gets an overall score of 4/5.